22 reports

  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Drug Discovery And Development
  • Malaria
  • World
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • PRODUCTS UNDER DEVELOPMENT BY UNIVERSITIES/INSTITUTES, H1 2018 (CONTD..1), H1 2018
  • MALARIA - PIPELINE BY CADILA HEALTHCARE LTD, H1 2018

Malaria - Overview Malaria - Therapeutics Development PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR MALARIA, H## 2018 NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR MALARIA, H## 2018 Pre-Registration ## ## Phase III ## ## Phase II ## ## Phase I ## ## Preclinical ## ## Discovery ## ## Unknow

  • Antimalarials
  • Malaria
  • Vaccine
  • United States
  • Sanaria Inc.
  • PRODUCTS UNDER DEVELOPMENT BY UNIVERSITIES/INSTITUTES, H2 2017 (CONTD..1), H2 2017
  • MALARIA - PIPELINE BY MICROBIOTIX INC, H2 2017

Malaria - Overview Malaria - Therapeutics Development PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR MALARIA, H## 2017 NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR MALARIA, H## 2017 Pre-Registration ## ## Phase III ## ## Phase II ## ## Phase I ## ## Preclinical ## ## Discovery ##

  • Antimalarials
  • Malaria
  • Vaccine
  • United States
  • Sanaria Inc.

Stem cell transplants cure more patients overall but up to one in four people die from complications of the transplant and a further one in four experience long-term side effects.

  • Malaria
  • United Kingdom
  • United States
  • World
  • Wellcome Trust

The molecules developed by companies in Preclinical and Discovery stages are ## and ## respectively.

  • Malaria
  • United States
  • World
  • Product Initiative
  • Epizyme, Inc.
  • GENEDRIVE - MALARIA ASSAY - PRODUCT DESCRIPTION
  • GENEDRIVE - MALARIA ASSAY - PRODUCT STATUS

This resulted in an EPS (before non-cash items) of ##. ## cents which, whilst lower than the equivalent quarter last year, was higher than the ## cent per ADR reported in quarter one of this year. "

  • Clinical Trial
  • Malaria
  • Point Of Care Testing
  • United States
  • GlobalData's company
  • MALARIA - PIPELINE BY GLAXOSMITHKLINE PLC
  • MALARIA - PIPELINE BY OSIVAX SAS

The company offers over-thecounter (OTC) products for pain relief, oral health, nutrition, skin health and gastrointestinal diseases.

  • Malaria
  • East Asia
  • Japan
  • United States
  • Product Initiative

GlobalData DesignMedix Inc, reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Healthcare
  • Malaria
  • United States
  • Deals & Alliance
  • DesignMedix
  • Cerebral (Fatal) Malaria - Pipeline by Eisai Co Ltd, H2 2016

The company' s franchise areas in research include neurology, oncology, vascular and immunological reaction, gastrointestinal disorders, and musculoskeletal diseases.

  • Malaria
  • Pathology
  • World
  • Product Initiative
  • Eisai Co., Ltd.

It is a small molecule that targets Mcl-##.

  • Malaria
  • Therapy
  • Australia
  • Social Conditions
  • GlobalData's company
  • DESIGNMEDIX, INC. - PIPELINE BY INDICATION, 2015

This report is a licensed product and is not to be photocopied DesignMedix, Inc. has promising clinical drug candidates for ## major therapeutic areas, Gastrointestinal and Infectious Disease.

  • Malaria
  • Pathology
  • United States
  • Company Operations
  • DesignMedix

The molecules developed by companies in Preclinical and Discovery stages are ## and ## respectively.

  • Malaria
  • Therapy
  • World
  • Product Initiative
  • Domainex Ltd
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Drug Discovery And Development
  • Infectious Disease
  • Malaria
  • World
  • GlaxoSmithKline plc

Small molecules act by targeting KMT-## (G##a).

  • Malaria
  • Therapy
  • United States
  • Product Initiative
  • Epizyme, Inc.

One of these, Galectin ##, encouraged development of a particular type of T cell when active.

  • Genetic
  • Malaria
  • United Kingdom
  • World
  • Thermo Fisher Scientific, Inc.

Partner ## Partner ## Deal status Deal category Deal sub-category Date of announcement COMPANY INFORMATION: PARTNERS Company type PARTNER ##: ANACOR PHARMACEUTICALS, INC.

  • Cardiology
  • Healthcare
  • Malaria
  • Pharmaceutical
  • Anacor Pharmaceuticals, Inc.

It treats various types of cancers such as anal cancer, bladder cancer, brain cancer, breast cancer, colorectal cancer, esophageal cancer, gallbladder cancer and gastrointestinal carcinoid tumor, among others.

  • Malaria
  • Pharmaceutical
  • United States
  • Company
  • Agilis Biotherapeutics, LLC
  • Zydus Cadila Healthcare Enters into Agreement with Medicines for Malaria Venture

" When the parasite develops resistance to one drug, it becomes more susceptible to the other.

  • Malaria
  • Pharmaceutical
  • Switzerland
  • United States
  • Company Operations
  • Clinical Trial profile. 367 Trial Title
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Clinical Trial
  • Infectious Disease
  • Malaria
  • Pharmaceutical
  • World

The most common adverse events reported in the Phase I clinical trials were related to the central nervous system and the gastrointestinal system.

  • Cancer
  • Malaria
  • Research And Development
  • Therapy
  • Eisai Co., Ltd.

PMX-## also showed MIC##s = ## g/ mL for B. anthracis and MIC##s = ## g/ mL for F. tularensis.

  • Malaria
  • Research And Development
  • United States
  • Company Operations
  • Cellceutix Corporation

Budesonide (Entocort, Entocort EC) is a gastrointestinal agent.

  • Blood Disease
  • Malaria
  • Therapy
  • United States
  • AstraZeneca PLC